320 related articles for article (PubMed ID: 22725947)
1. Rapamycin-mediated suppression of renal cyst expansion in del34 Pkd1-/- mutant mouse embryos: an investigation of the feasibility of renal cyst prevention in the foetus.
Stayner C; Shields J; Slobbe L; Shillingford JM; Weimbs T; Eccles MR
Nephrology (Carlton); 2012 Nov; 17(8):739-47. PubMed ID: 22725947
[TBL] [Abstract][Full Text] [Related]
2. Comparison of folate-conjugated rapamycin versus unconjugated rapamycin in an orthologous mouse model of polycystic kidney disease.
Kipp KR; Kruger SL; Schimmel MF; Parker N; Shillingford JM; Leamon CP; Weimbs T
Am J Physiol Renal Physiol; 2018 Aug; 315(2):F395-F405. PubMed ID: 29717938
[TBL] [Abstract][Full Text] [Related]
3. A study of sirolimus and mTOR kinase inhibitor in a hypomorphic
Holditch SJ; Brown CN; Atwood DJ; Lombardi AM; Nguyen KN; Toll HW; Hopp K; Edelstein CL
Am J Physiol Renal Physiol; 2019 Jul; 317(1):F187-F196. PubMed ID: 31042058
[TBL] [Abstract][Full Text] [Related]
4. Double inhibition of cAMP and mTOR signalling may potentiate the reduction of cell growth in ADPKD cells.
de Stephanis L; Bonon A; Varani K; Lanza G; Gafà R; Pinton P; Pema M; Somlo S; Boletta A; Aguiari G
Clin Exp Nephrol; 2017 Apr; 21(2):203-211. PubMed ID: 27278932
[TBL] [Abstract][Full Text] [Related]
5. Curcumin inhibits cystogenesis by simultaneous interference of multiple signaling pathways: in vivo evidence from a Pkd1-deletion model.
Leonhard WN; van der Wal A; Novalic Z; Kunnen SJ; Gansevoort RT; Breuning MH; de Heer E; Peters DJ
Am J Physiol Renal Physiol; 2011 May; 300(5):F1193-202. PubMed ID: 21345977
[TBL] [Abstract][Full Text] [Related]
6. Pax2 gene dosage influences cystogenesis in autosomal dominant polycystic kidney disease.
Stayner C; Iglesias DM; Goodyer PR; Ellis L; Germino G; Zhou J; Eccles MR
Hum Mol Genet; 2006 Dec; 15(24):3520-8. PubMed ID: 17082250
[TBL] [Abstract][Full Text] [Related]
7. Ablation of Long Noncoding RNA Hoxb3os Exacerbates Cystogenesis in Mouse Polycystic Kidney Disease.
Weisser I; Eckberg K; D'Amico S; Buttram D; Aboudehen K
J Am Soc Nephrol; 2024 Jan; 35(1):41-55. PubMed ID: 37953472
[TBL] [Abstract][Full Text] [Related]
8. Autophagy activators suppress cystogenesis in an autosomal dominant polycystic kidney disease model.
Zhu P; Sieben CJ; Xu X; Harris PC; Lin X
Hum Mol Genet; 2017 Jan; 26(1):158-172. PubMed ID: 28007903
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of accelerated renal cystogenesis in Pkd1 mice by renin-angiotensin system blockade.
Fitzgibbon WR; Dang Y; Bunni MA; Baicu CF; Zile MR; Mullick AE; Saigusa T
Am J Physiol Renal Physiol; 2018 Feb; 314(2):F210-F218. PubMed ID: 29021226
[TBL] [Abstract][Full Text] [Related]
10. Cux1 promotes cell proliferation and polycystic kidney disease progression in an ADPKD mouse model.
Porath B; Livingston S; Andres EL; Petrie AM; Wright JC; Woo AE; Carlton CG; Baybutt R; Vanden Heuvel GB
Am J Physiol Renal Physiol; 2017 Oct; 313(4):F1050-F1059. PubMed ID: 28701314
[TBL] [Abstract][Full Text] [Related]
11. Rapamycin treatment dose-dependently improves the cystic kidney in a new ADPKD mouse model via the mTORC1 and cell-cycle-associated CDK1/cyclin axis.
Li A; Fan S; Xu Y; Meng J; Shen X; Mao J; Zhang L; Zhang X; Moeckel G; Wu D; Wu G; Liang C
J Cell Mol Med; 2017 Aug; 21(8):1619-1635. PubMed ID: 28244683
[TBL] [Abstract][Full Text] [Related]
12. Triptolide reduces cyst formation in a neonatal to adult transition Pkd1 model of ADPKD.
Leuenroth SJ; Bencivenga N; Chahboune H; Hyder F; Crews CM
Nephrol Dial Transplant; 2010 Jul; 25(7):2187-94. PubMed ID: 20139063
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA
Aboudehen K; Farahani S; Kanchwala M; Chan SC; Avdulov S; Mickelson A; Lee D; Gearhart MD; Patel V; Xing C; Igarashi P
J Biol Chem; 2018 Jun; 293(24):9388-9398. PubMed ID: 29716997
[TBL] [Abstract][Full Text] [Related]
14. The regulatory 1α subunit of protein kinase A modulates renal cystogenesis.
Ye H; Wang X; Constans MM; Sussman CR; Chebib FT; Irazabal MV; Young WF; Harris PC; Kirschner LS; Torres VE
Am J Physiol Renal Physiol; 2017 Sep; 313(3):F677-F686. PubMed ID: 28615245
[TBL] [Abstract][Full Text] [Related]
15. Metformin improves relevant disease parameters in an autosomal dominant polycystic kidney disease mouse model.
Pastor-Soler NM; Li H; Pham J; Rivera D; Ho PY; Mancino V; Saitta B; Hallows KR
Am J Physiol Renal Physiol; 2022 Jan; 322(1):F27-F41. PubMed ID: 34806449
[TBL] [Abstract][Full Text] [Related]
16. Lysine methyltransferase SMYD2 promotes cyst growth in autosomal dominant polycystic kidney disease.
Li LX; Fan LX; Zhou JX; Grantham JJ; Calvet JP; Sage J; Li X
J Clin Invest; 2017 Jun; 127(7):2751-2764. PubMed ID: 28604386
[TBL] [Abstract][Full Text] [Related]
17. Pkd2 Deficiency in Embryonic Aqp2 + Progenitor Cells Is Sufficient to Cause Severe Polycystic Kidney Disease.
Tsilosani A; Gao C; Chen E; Lightle AR; Shehzad S; Sharma M; Tran PV; Bates CM; Wallace DP; Zhang W
J Am Soc Nephrol; 2024 Apr; 35(4):398-409. PubMed ID: 38254271
[TBL] [Abstract][Full Text] [Related]
18. Rapamycin ameliorates PKD resulting from conditional inactivation of Pkd1.
Shillingford JM; Piontek KB; Germino GG; Weimbs T
J Am Soc Nephrol; 2010 Mar; 21(3):489-97. PubMed ID: 20075061
[TBL] [Abstract][Full Text] [Related]
19. Aquaporin-3 deficiency slows cyst enlargement in experimental mouse models of autosomal dominant polycystic kidney disease.
Wang W; Geng X; Lei L; Jia Y; Li Y; Zhou H; Verkman AS; Yang B
FASEB J; 2019 May; 33(5):6185-6196. PubMed ID: 30768374
[TBL] [Abstract][Full Text] [Related]
20. Adenylyl cyclase 5 deficiency reduces renal cyclic AMP and cyst growth in an orthologous mouse model of polycystic kidney disease.
Wang Q; Cobo-Stark P; Patel V; Somlo S; Han PL; Igarashi P
Kidney Int; 2018 Feb; 93(2):403-415. PubMed ID: 29042084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]